论文信息 - Phase I safety, pharmacokinetic and pharmacodynamic trial of BMS-599626 (AC480), an oral pan-HER receptor tyrosine kinase inhibitor, in patients with advanced solid tumors. - 字舞流文

Phase I safety, pharmacokinetic and pharmacodynamic trial of BMS-599626 (AC480), an oral pan-HER receptor tyrosine kinase inhibitor, in patients with advanced solid tumors.

J. Baselga | J. Soria | J. Cortes | J. Armand | J. Marier | R. Martell | C. Massard | M. Béliveau | A. Catteau | S. Ropert | E. Lopez | J. James | D. De Andreis | J-C. Soria | J. Baselga | J. Cortes | D. D. Andreis | S. Ropert | Jean-Francois Marier